Anti-obesity medications: Risks, benefits and alternatives
Kresge Buildinghttps://www.youtube.com/watch?v=zBknkJIGPzs Prescriptions for anti-obesity medications have soared. A wave of next-generation therapies is on the way. And researchers are studying whether GLP-1 drugs such as Ozempic, Wegovy, and Mounjaro can have impacts beyond obesity and diabetes, based on emerging clues that they could target addiction, cardiovascular disease, osteoarthritis — even potentially neurodegenerative disorders such as...